Charles River Posts Q2 Revenue of $1.0B, Net Loss Driven by $63.7M Divestiture Charge
CRL sits 78% above its 52-week low of $144.26.
Summary
Charles River reported Q2 revenue of $1.0 billion and a net loss of $1.5 million, driven by a $63.7 million divestiture loss. The company is restructuring, acquiring a key NHP supplier, and the CEO adopted a 10b5-1 trading plan.
Key Events · Earnings and Guidance · CRL
-
Q2 Revenue $1.0B, Net Loss $1.5M
Revenue of $1.004 billion was down 2.7% year-over-year, while a net loss of $1.5 million was driven by a $63.7 million loss on the CDMO and Cell Solutions divestiture.
-
Divestiture Losses Reshape Portfolio
The CDMO and Cell Solutions sale to GI Partners resulted in a $63.7 million pre-tax loss this quarter ($181.7 million YTD). The European Discovery sale to IQVIA yielded a $0.3 million gain.
-
Cambodian NHP Supplier Acquired for $507M
The acquisition of a Cambodian non-human primate supplier closed in January 2026 for $507.3 million, securing a critical supply chain for the DSA segment.
-
Restructuring Charges Continue
Restructuring costs were $23.1 million in Q2 and $54.6 million YTD, part of a plan to achieve $300 million in annualized savings by end of 2026.
Analysis · CRL · Industrial Applications And Services
Charles River's Q2 results present a mixed picture: revenue held at $1.0 billion, but a net loss of $1.5 million was driven by a $63.7 million loss on the CDMO and Cell Solutions divestiture. Operating income improved to $119.9 million from $100.1 million a year ago, helped by lower amortization and a gain on a sale-leaseback. The company is actively reshaping its portfolio—selling underperforming businesses while acquiring a Cambodian NHP supplier for $507 million to secure a critical supply chain. Restructuring charges of $23.1 million this quarter reflect ongoing cost-cutting. The CEO adopted a 10b5-1 plan to sell up to 14,000 shares starting September 1, which may weigh on sentiment despite the operational improvements.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CRL was trading at $257.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $11.3B. The 52-week trading range was $144.26 to $242.73. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.